Bioneex is the first AI-powered drug candidates marketplace. It connects drug development companies with biopharma partners and venture capital investors to facilitate licensing, co-development partnership deals for preclinical and clinical-stage drug candidates, and investments.
On one side, the platform enables innovative drug development companies to list their novel drug candidates and directly contact hundreds of biopharma partners and venture capital investors actively seeking development-stage assets (preclinical to phase III) for in-licensing, co-development partnership, and investment.
On the other side, the platform enables biopharma companies and venture capital firms to identify and access novel development-stage assets (preclinical to phase III) posted directly by drug development companies and directly contact them with one click.
In essence, Bioneex provides a platform for drug development companies, biopharma partners and venture capital investors, where they can meet and create R&D partnerships and investment deals.
Bioneexs vision is helping preclinical and clinical-stage drug development companies gain for their medicines in development vital exposure to the right partners and investors at the right time, which will increase the likelihood of moving these innovative drug candidates into the next stage of development and, ultimately to the patients as novel medicines.
